A mixture model of nuchal translucency thickness in screening for chromosomal defects
Open Access
- 28 March 2008
- journal article
- research article
- Published by Wiley in Ultrasound in Obstetrics & Gynecology
- Vol. 31 (4) , 376-383
- https://doi.org/10.1002/uog.5299
Abstract
Objective Fetal nuchal translucency (NT) thickness increases with crown–rump length (CRL). In screening for chromosomal defects patient‐specific risks are derived by multiplying the a priori maternal age‐related risk by a likelihood ratio, determined from the deviation of the measured NT from the expected median. To quantify this deviation the measured NT is either subtracted (delta NT) or divided by the expected median (multiple of the median method, MoM). This study examines the validity of these methods. Methods NT was prospectively measured at 11 + 0 to 13 + 6 weeks in screening for chromosomal defects. The distribution of NT in euploid and chromosomally abnormal fetuses was examined. Results There were 37 078 normal pregnancies and 264 with trisomy 21, 81 with trisomy 18, 38 with trisomy 13 and 27 with Turner syndrome. We found that firstly, contrary to the assumption underlying the delta NT method, the distribution of delta NT changes with CRL and secondly, contrary to the assumption underlying the MoM method the distribution of NT was not Gaussian. Fetal NT followed two distributions, one that was dependent on CRL and one that was independent of CRL. The distribution in which NT increases with CRL was observed in about 95% of euploid fetuses, 5% with trisomy 21, 30% with trisomy 18, 15% with trisomy 13 and 10% with Turner syndrome. The median CRL‐independent NT was 2.0 mm for the euploid group and 3.4, 5.5, 4.0 and 7.8 mm for trisomies 21, 18, 13 and Turner syndrome, respectively. Conclusions The NT thickness in chromosomally normal and abnormal fetuses follows a mixture of a gestation‐dependent and gestation‐independent distribution. Copyright © 2008 ISUOG. Published by John Wiley & Sons, Ltd.Keywords
This publication has 20 references indexed in Scilit:
- Comparison of Serum Markers in First-Trimester Down Syndrome ScreeningObstetrics & Gynecology, 2006
- Prospective first-trimester screening for trisomy 21 in 30,564 pregnanciesAmerican Journal of Obstetrics and Gynecology, 2005
- Delta‐NT or NT MoM: which is the most appropriate method for calculating accurate patient‐specific risks for trisomy 21 in the first trimester?Ultrasound in Obstetrics & Gynecology, 2003
- First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS)Health Technology Assessment, 2003
- Estimating the spontaneous loss of Down syndrome fetuses between the times of chorionic villus sampling, amniocentesis and livebirthPrenatal Diagnosis, 1998
- UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestationThe Lancet, 1998
- Letter. Correct estimation of parameters for ultrasound nuchal translucency screeningPrenatal Diagnosis, 1998
- Maternal Age and Gestational Age-Specific Risk for Chromosomal DefectsFetal Diagnosis and Therapy, 1995
- A Language and Program for Complex Bayesian ModellingJournal of the Royal Statistical Society: Series D (The Statistician), 1994
- Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha‐fetoprotein levelBJOG: An International Journal of Obstetrics and Gynaecology, 1987